when will the semaglutide shortage end Wegovy Continues, Leaving Patients On the Weight Loss Drug in Limbo End of Semaglutide Shortage Means

(Source: NEJM SELECT Trial, 2023) Semaglutide Also Reduces Fatty Liver Disease Risk A 2026 analysis of the SELECT trial found that semaglutide also reduces major heart events and lowers fatty liver disease risk in adults with both obesity and heart disease

Last reviewed: May 12, 2026 Last updated: May 12, 2026 Written by: Jay Hastings , CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

Prescription products are available only after an online consultation with a licensed U.S

Why does semaglutide have to be refrigerated